3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
55
Breast Neoplasms
38
Prostatic Neoplasms
29
Lung Neoplasms
28
Multiple Myeloma
22
Neoplasms
19
Ovarian Neoplasms
17
Colorectal Neoplasms
17
Leukemia, Lymphocytic, Chronic, B-Cell
16
Neoplasm Metastasis
15
Parkinson Disease 4, Autosomal Dominant Lewy Body
14
Carcinoma, Renal Cell
13
Endometrial Neoplasms
12
Small Cell Lung Carcinoma
11
Pancreatic Neoplasms
11
Urinary Bladder Neoplasms
10
Stomach Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Lymphoma, Follicular
9
Fallopian Tube Neoplasms
9
Non-Muscle Invasive Bladder Neoplasms
8
Myasthenia Gravis
8
Leukemia, Myeloid, Acute
8
Colonic Neoplasms
8
Burkitt Lymphoma
7
Recurrence
6
Esophageal Neoplasms
6
Adenocarcinoma
6
Triple Negative Breast Neoplasms
5
Melanoma
5
Interventions
vinflunine
1
sacituzumab govitecan
1
Paclitaxel
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Locally Advanced or Metastatic Unresectable Urothelial Cancer
×
30 days
×
Clear all
NCT04527991
2026-06-02
TROPiCS-04
Gilead Sciences
Phase 3
Completed
711 enrolled
25 charts